For sales

Highlights from the Week of 14 July , 2025 – 21 July, 2025 in the world of pharma and healthcare! 

Highlights from the Week of July 14 - 21, 2025 Nanoscope Therapeutics ( Rare Disease, Eye Disease ) Nanoscope Therapeutics starts rolling BLA submission to the FDA for MCO‑010, the first gene‑agnostic therapy for retinitis pigmentosa Praxis ( Breakthroughs, Epilepsy ) Praxis’s relutrigine has been granted FDA breakthrough status for the treatment of SCN2A- and SCN8A-associated developmental epileptic encephalopathies Illimis Therapeutics ( Financing, Drug Development ) Illimis Therapeutics has successfully completed a 58 billion KRW ($42 million) Series B financing round to accelerate its drug development efforts for CNS and immune diseases using its GAIA platform Endeavour BioMedicines ( Orphan Drugs, Pulmonary Fibrosis) Endeavor BioMedicines receives orphan drug designation from the FDA and European Commission for taladegib (ENV‑101) in the treatment of idiopathic pulmonary fibrosis All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.